Raysearch Laboratories
225.00 SEK
+0.22 %
Less than 1K followers
RAY B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+0.22 %
-12.28 %
-5.06 %
-31.61 %
+4.17 %
+9.22 %
+300.36 %
+191.07 %
+303.40 %
RaySearch Laboratories operates in the medical technology industry and focuses on the development and manufacture of software for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The operations are international and target customers globally. Laboratories was founded in 2000 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
7.71B SEK
Turnover
11.69M SEK
Revenue
1.19B
EBIT %
21.85 %
P/E
37.88
Dividend yield-%
1.33 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12.2
2026
Annual report '25
29.4
2026
Interim report Q1'26
7.5
2026
General meeting '26
All
Webcasts
Press releases
ShowingAll content types
Redeye: RaySearch Laboratories (Q3 Review) - EBIT beat reinforces take on conservative targets
RaySearch Laboratories, Audiocast, Q3'25
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools